Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Boyd, Allison L  [Clear All Filters]
2024
Hollands CG, Boyd AL, Zhao X, Reid JC, Henly C, Elrafie A, Boylan D, Broder E, Kalau O, Johnson P, et al. Identification of cells of leukemic stem cell origin with non-canonical regenerative properties. Cell Rep Med. 2024:101485.
2023
Orlando L, Benoit YD, Reid JC, Nakanishi M, Boyd AL, García-Rodríguez JL, Tanasijevic B, Doyle MS, Luchman A, Restall IJ, et al. Chemical genomics reveals targetable programs of human cancers rooted in pluripotency. Cell Chem Biol. 2023.
Boyd AL, Lu J, Hollands CG, Alsostovar L, Murali S, Reid JC, Ye W, Vandersluis S, Johnson P, Elrafie A, et al. Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemia. Cell Rep Med. 2023:101108.
Golubeva D, Porras DP, Doyle M, Reid JC, Tanasijevic B, Boyd AL, Vojnits K, Elrafie A, Qiao A, Bhatia M. Reprogramming of Acute Myeloid Leukemia Patients Cells: Harboring Cancer Mutations Requires Targeting of AML Hierarchy. Stem Cells Transl Med. 2023.
2021
Reid JC, Golubeva D, Boyd AL, Hollands CG, Henly C, Orlando L, Leber A, Hébert J, Morabito F, Cutrona G, et al. Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patients. Cell Rep. 2021;34(11):108845.
Orlando L, Tanasijevic B, Nakanishi M, Reid JC, García-Rodríguez JL, Chauhan KDev, Porras DP, Aslostovar L, Lu JD, Shapovalova Z, et al. Phosphorylation state of the histone variant H2A.X controls human stem and progenitor cell fate decisions. Cell Rep. 2021;34(10):108818.
Benoit YD, Mitchell RR, Wang W, Orlando L, Boyd AL, Tanasijevic B, Aslostovar L, Shapovalova Z, Doyle M, Bergin CJ, et al. Targeting SUMOylation dependency in human cancer stem cells through a unique SAE2 motif revealed by chemical genomics. Cell Chem Biol. 2021.
2018
Boyd AL, Aslostovar L, Reid J, Ye W, Tanasijevic B, Porras DP, Shapovalova Z, Almakadi M, Foley R, Leber B, et al. Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence. Cancer Cell. 2018;34(3):483-498.e5.
2014
Benoit YD, Guezguez B, Boyd AL, Bhatia M. Molecular Pathways: Epigenetic Modulation of Wnt/Glycogen Synthase Kinase-3 Signaling to Target Human Cancer Stem Cells. Clin Cancer Res. 2014.